Drug Index 2.0 is hereOur new update features a more powerful search feature and easier login.
issues? Contact us
today. Contact Us
Mode of Action
Possibility of thromboembolic disorder and tumour needs to be ruled out; contraceptive efficacy may be reduced in women weighing equal or greater than 90 kg. Irregular menstruation during the first 3 to 6 months of use
Allergy to the drug or any other component of the product; undiagnosed abnormal genital bleeding; diabetes melitus with vascular involvement; history of venous thrombosis; migraine with focal aura; history of arterial thrombosis; severe hypertension
Vaginal fungal infection; hypersensi-tivity to the components of the formulation; head-ache; nausea; breast tenderness; mood, affect and anxiety disorders; migraine; dizziness; abdominal pain; vomiting; diarrhoea; abdominal distension; weight increase; odema; dysmennorhoea; vaginal bleeding; menstrual bleeding.